AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75F40121C00127THE JOHNS HOPKINS UNIVERSITY
Overview
Award facts
- Net obligations
- $307.03K
- $307,034of $307.03K potential value
- Outlays (paid to date)
- $307.03K
- $307.03K paid of $307.03K obligated$307,034
- Period of performance
- Sep 27, 2021 to Sep 28, 2023
- Ended
- Modifications
- 3
- Latest action Jul 12, 2026
- Contract type
- Definitive contract
- PIID 75F40121C00127
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
EVALUATING THE IMPACT OF EXTENDED-INFUSION BETA-LACTAM ADMINISTRATION STRATEGIES ON IMPROVING CLINICAL OUTCOMES AND REDUCING THE SUBSEQUENT EMERGENCE OF ANTIMICROBIAL RESISTANCE-BAA-PMWP#173.
Dates and value
- Award date
- Signed on Sep 27, 2021
- Current value
- $307,034Base and exercised options
- Potential value (if all options are exercised)
- $307,034
Obligations by fiscal year of action
- FY2026: -$171 (de-obligation)
- FY2021: $307,205
Total across 2 fiscal years: $307,034
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 12, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationBALTIMORE, MD
UEIFTMTDMBR29C7
CAGE code5L406
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companyTHE JOHNS HOPKINS HEALTH SYSTEM CORPORATION
Business types and certifications
Nonprofit organizationEducational institutionTax-exempt corporation
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugsProgram activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Baltimore, Baltimore City, Maryland 21205-3102
- Congressional district (place of performance)
- MD-07As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN41HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Basic researchBR
- Set-aside
- No set-aside used
- Contract pricing
- Cost no feeS
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- FDABAA-21-00123
- Solicitation date
- Apr 29, 2021
- Notices
- Solicitation posted May 25, 2021
- Solicitation posted May 25, 2021
- Solicitation posted Jan 28, 2021
- Solicitation posted Nov 20, 2020
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 27, 2021Base obligation at award: $307,205
- Latest action
- Jul 12, 2026 — CloseoutModification P00003; obligation change -$171; administrative: no change in scope or value
- Actions by type
- Base award1
- Other administrative action2
- Closeout1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$171
- Latest action: change in base and all options
- -$171
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- Other U.S. entity (e.g. government)B
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2021/2021-0600-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression